The largest community of pharma leaders

Industry News

Syros Announces Strategic Priorities and Expected Milestones

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today outlined its strategic priorities...

Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe

DUBLIN & CAMBRIDGE, United Kingdom & BRISBANE, Australia--(BUSINESS WIRE)--Inflazome (, the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful inflammation,...

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule...

Recent Articles